Ginkgo Bioworks Holdings annual operating expenses
2019
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Operating Expenses Growth & History (DNA)
Ginkgo Bioworks Holdings's operating expenses was $485.4M for fiscal 2025.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $485.4M | −$301.4M | −38.30% |
| 2024 | 2024-12-31 | $786.8M | −$329.1M | −29.49% |
| 2023 | 2023-12-31 | $1.12B | −$1.57B | −58.47% |
| 2022 | 2022-12-31 | $2.69B | $544.4M | +25.41% |
| 2021 | 2021-12-31 | $2.14B | $1.93B | +902.56% |
| 2020 | 2020-12-31 | $213.7M | $87.9M | +69.88% |
| 2019 | 2019-12-31 | $125.8M | — | — |
Ginkgo Bioworks Holdings quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $78.7M | −$18.6M | −19.11% |
| Q1 2026 | 2026-03-31 | $90.8M | −$28.4M | −23.79% |
| Q4 2025 | 2025-12-31 | $140.1M | −$7.4M | −5.00% |
| Q3 2025 | 2025-09-30 | $128.9M | −$15.4M | −10.67% |
| Q2 2025 | 2025-06-30 | $97.3M | −$181.9M | −65.15% |
| Q1 2025 | 2025-03-31 | $119.2M | −$96.7M | −44.80% |
| Q4 2024 | 2024-12-31 | $147.5M | −$65.4M | −30.73% |
| Q3 2024 | 2024-09-30 | $144.3M | −$197.6M | −57.80% |
| Q2 2024 | 2024-06-30 | $279.2M | $14.4M | +5.45% |
| Q1 2024 | 2024-03-31 | $215.9M | −$80.5M | −27.16% |
| Q4 2023 | 2023-12-31 | $212.9M | −$116.3M | −35.33% |
| Q3 2023 | 2023-09-30 | $341.8M | −$379.5M | −52.61% |
| Q2 2023 | 2023-06-30 | $264.7M | −$527.7M | −66.59% |
| Q1 2023 | 2023-03-31 | $296.4M | −$547.3M | −64.87% |
| Q4 2022 | 2022-12-31 | $329.1M | −$1.50B | −82.05% |
| Q3 2022 | 2022-09-30 | $721.3M | $617.1M | +591.72% |
| Q2 2022 | 2022-06-30 | $792.4M | $688.8M | +665.00% |
| Q1 2022 | 2022-03-31 | $843.8M | $742.6M | +733.67% |
| Q4 2021 | 2021-12-31 | $1.83B | — | — |
| Q3 2021 | 2021-09-30 | $104.3M | $56.6M | +118.55% |
| Q2 2021 | 2021-06-30 | $103.6M | — | — |
| Q1 2021 | 2021-03-31 | $101.2M | — | — |
| Q3 2020 | 2020-09-30 | $47.7M | — | — |
Ginkgo Bioworks Holdings operating expenses trends
Over the last five fiscal years, Ginkgo Bioworks Holdings's operating expenses increased from $213.7M to $485.4M, a change of $271.7M. The latest reported quarter, Q2 2026, shows $78.7M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...